Bryan P Yan; Darragh Moran, MD; Brian G Hynes, MD; Thomas J Kiernan, MD; Cheuk-Man Yu, MD
Critical limb ischemia (CLI) represents the most severe clinical manifestation of peripheral arterial disease. In the absence of timely revascularization, CLI carries high risk of mortality and amputation. Over the past decade, endovascular revascularization has rapidly become the preferred primary treatment strategy for CLI, especially for the treatment of below-the-knee disease. Advances in percutaneous devices and techniques have expanded the spectrum of patients with CLI who are deemed candidates for revascularization. This review will focus on advances in endovascular options for the treatment of CLI, in particular for below-the-knee disease.
All rights are reserved to the Japanese Circulation Society.
Full Text: PDF
Online Publication: Found Here